Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update Life Science Investing
Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer's Disease Conference Life Science Investing
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics Biotech Investing
Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength Life Science Investing
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry Biotech Investing
Avidity Biosciences Announces U.S. Managed Access Program for Investigational Therapy del-zota in DMD44 Life Science Investing
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 Life Science Investing
RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th Life Science Investing
Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist for Central Disorders of Hypersomnolence Life Science Investing
Quantum-Si to Highlight Significant Proteus Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day Life Science Investing
